{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T03:40:54Z","timestamp":1689392454856},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,7,15]]},"DOI":"10.2169\/internalmedicine.0988-22","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T22:11:14Z","timestamp":1669155074000},"page":"2085-2088","source":"Crossref","is-referenced-by-count":1,"title":["Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline"],"prefix":"10.2169","volume":"62","author":[{"given":"Yuki","family":"Shibuya","sequence":"first","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Shiba","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaharu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amane","family":"Mitake","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Aizenbashi Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ichibori","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Minamiguchi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Makino","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bauersachs J, K\u00f6nig T, van der Meer P, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 21: 827-843, 2019.","DOI":"10.1002\/ejhf.1493"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Davis MB, Arany Z, McNamara DM, et al. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 75: 207-221, 2020.","DOI":"10.1016\/j.jacc.2019.11.014"},{"key":"3","unstructured":"3. Isezuo SA, Abubakar SA. Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethn Dis 17: 228-233, 2007."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kolte D, Khera S, Aronow WS. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 3: e001056, 2014.","DOI":"10.1161\/JAHA.114.001056"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kamiya CA, Kitakaze M, Ishibashi-Ueda H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese nationwide survey of peripartum cardiomyopathy. Circ J 75: 1975-1981, 2011.","DOI":"10.1253\/circj.CJ-10-1214"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hilfiker-Kleiner D, Kaminski K, Podewski E, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 28: 589-600, 2007.","DOI":"10.1016\/j.cell.2006.12.036"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tremblay-Gravel M, Marquis-Gravel G, Avram R, et al. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study. ESC Heart Fail 6: 27-36, 2019.","DOI":"10.1002\/ehf2.12376"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hilfiker-Kleiner D, Haghikia A, Berliner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 38: 2671-2679, 2017.","DOI":"10.1093\/eurheartj\/ehx355"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Haghikia A, Podewski E, Libhaber E, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 108: 366, 2013.","DOI":"10.1007\/s00395-013-0366-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bonnar J, Franklin M, Nott PN, McNeilly AS. Effect of breast-feeding on pituitary-ovarian function after childbirth. Br Med J 4: 82-84, 1975.","DOI":"10.1136\/bmj.4.5988.82"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121: 1465-1473, 2010.","DOI":"10.1161\/CIRCULATIONAHA.109.901496"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hoevelmann J, Engel ME, Muller E, et al. A global perspective on the management and outcomes of peripartum cardiomyopathy: a systematic review and meta-analysis. Eur J Heart Fail 24: 1719-1736, 2022.","DOI":"10.1002\/ejhf.2603"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Rains CP, Bryson HM, Fitton A. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation. Drugs 49: 255-279, 1995.","DOI":"10.2165\/00003495-199549020-00009"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sabuncu T, Arikan E, Tasan E, et al. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Intern Med 40: 857-861, 2001.","DOI":"10.2169\/internalmedicine.40.857"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. dos Santos Nunes V, El Dib R, Boguszewski CL, Nogueira CR. Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis. Pituitary 14: 259-265, 2011.","DOI":"10.1007\/s11102-010-0290-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Caruso G, Scopelliti A, Scaramuzzino S, et al. Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: a case report and review of the literature. Case Rep Womens Health 29: e00277, 2020.","DOI":"10.1016\/j.crwh.2020.e00277"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ersb\u00f8ll AS, Johansen M, Damm P, Rasmussen S, Vejlstrup NG, Gustafsson F. Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. Eur J Heart Fail 19: 1712-1720, 2017.","DOI":"10.1002\/ejhf.882"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/14\/62_0988-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T03:22:20Z","timestamp":1689391340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/14\/62_0988-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":17,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.0988-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"article-number":"0988-22"}}